Risk of second primary lung cancer in patients with thyroid cancer: a meta-analysis based on big population studies.

ABSTRACT:

Background

Previous studies have revealed that the number of cancer survivors developing a second primary malignancy is increasing, especially among thyroid cancer patients, and lung cancer is still the main cause of cancer death. Therefore, we aimed to investigate the risk of second primary lung cancer (SPLC) in patients with thyroid cancer.

Methods

We searched the PubMed, Web of Science, Embase, and Scopus databases up to November 24, 2021, for relevant research and merged the standardized incidence ratios (SIRs) and 95% confidence intervals (95% CIs) to evaluate the risk of developing SPLC in patients with thyroid cancer.

Results

Fourteen studies involving 1,480,816 cases were included in our meta-analysis. The pooled result demonstrated that thyroid cancer patient

SUBMITTER: Wang H 

PROVIDER: S-EPMC10325762 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature